OSCR

Early effects of a novel 5-HT<sub>4</sub>R agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: RESTAND study.

Code ↔ Paper

5 matches between paragraphs of the paper and lines of its authors' code, computed by the harvester (lexical-v1). Click a colored paragraph or line to see its counterpart.

The 5 matches · 1 of them tie a paragraph to a whole file, not to given lines: a weak match, whose lines are not tinted
  1. [1] § Results › On a neuroimaging measure of emotional cognition, participants who received the 5-HT4 agonist showed a distinct pattern of neural changes to those on citalopram, with increased medial-fronta ↔ Emotional Cognition paper scripts/06_fmri_wholebrain_clusters.R, lines 1–80 · score 0.80 · middle temporal gyrus, angular gyrus, fusiform gyrus, lateral occipital, cerebellum, clusters
  2. [2] § Methods › Clinical assessment and questionnaire measures ↔ Emotional Cognition paper scripts/02_demographic_comparison.R, the whole file · a weak match · score 0.67 · Trait Anxiety, anhedonic symptoms, Inventory, STAI, depression, baseline
  3. [3] § Methods › Statistical analysis › Magnetic Resonance Imaging Data ↔ Emotional Cognition paper scripts/07_ROI_analysis.R, lines 417–490 · score 0.62 · medial frontal cortex, BOLD signal change, ROI, amygdala, placebo, citalopram
  4. [4] § Methods › Clinical assessment and questionnaire measures ↔ Emotional Cognition paper scripts/09_selfreport.R, lines 1–52 · score 0.58 · anhedonic symptoms, research visits, PANAS, VAS, STAI, depression
  5. [5] § Results › After one week, participants given either PF-04995274 or citalopram showed significant decreases in depressive symptoms › Self-reported symptoms and affect ↔ Emotional Cognition paper scripts/09_selfreport.R, lines 1–52 · score 0.51 · depressive symptoms, state anxiety, BDI, STAI, visit

Paper

Loaded from Europe PMC by your browser, not stored by OSCR: doi.org · Europe PMC

The paper is loaded when this pane is shown.

The authors' code

R · 266 lines · 10 KB · no license · 2 matches

This file is not shown here: its repository has no license, so its authors keep all their rights to it. Your browser cannot show it from its source either: OSF does not let the page of another site read its files.

It can be read at the source: Emotional Cognition paper scripts/09_selfreport.R.

Overview

Authors: A.L. Gillespie1,2, A.N. de Cates1,3, J. Scaife1, M. Blandhol4,5, M.A.G. Martens1,2, D Gibson, B.R Godlewska1,2, W Howard1, P.J. Cowen1,2, S.E. Murphy1,2, C.J. Harmer1,2
  1. University Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK
  2. Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK
  3. Institute for Mental Health, University of Birmingham, Edgbaston, Birmingham, UK
  4. Department of Physics and Computational Radiology, Oslo University Hospital, Norway
  5. Faculty of Medicine, University of Oslo
Institutions: Warneford Hospital (United Kingdom); University of Oxford (United Kingdom); Oxford Health NHS Foundation Trust (United Kingdom); University of Birmingham (United Kingdom); Oslo University Hospital (Norway); University of Oslo (Norway)
Dates: published online 28 May 2026; in print 28 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1192/bjp.2026.10664 · PMID 42204761 · PMCID PMC7619257 · OpenAlex W7162667037
Open access: hybrid, a free copy (OpenAlex)
Status: code verified
Categories: human (organism), depression (population), cognitive (subfield)
Methods: Statistics, fMRI & imaging
Keywords: Psychopharmacology, Antidepressants, Cognitive Neuroscience, Neuroimaging, Depressive Disorders
Topic: Treatment of Major Depression (Pharmacology, Medicine), according to OpenAlex
Funding: Medical Research Council (MR/P012604/1); Wellcome Trust (216430/Z/19/Z)
Citations: cited by 1 paper (Europe PMC); 48 references in the paper

Abstract

Background: Selective serotonin reuptake inhibitors (SSRIs) are limited by inadequate response in a significant proportion of patients, slow onset, minimal cognitive benefit, and side effects. Preclinical studies suggest selective serotonin 4 receptor (5-HT4R) agonists may produce faster antidepressant effects via distinct mechanisms, however there has been no experimental research in clinical populations to date.

Aims: To test whether the novel 5-HT4R partial agonist PF-04995274 produces early behavioural and neural changes in emotional cognition similar to SSRIs in patients with unmedicated major depressive disorder (MDD).

Method: In a double-blind, placebo-controlled trial, 90 participants with MDD were randomised to 7 days of PF-04995274 (15 mg), citalopram (20 mg), or placebo. Emotional processing was assessed using a behavioural facial expression recognition task and fMRI of implicit emotional face processing (days 6–9). Observer- and self-reported symptoms of depression were also measured at baseline and study end.

Results: As anticipated, citalopram reduced relative accuracy and increased relative reaction time to identify negative faces, with corresponding changes in neural activity (reduced left amygdala activation to emotional faces and valence-specific shifts in cortical regions). In contrast, PF-04995274 produced no change in behavioural negative bias or amygdala activity but increased medial-frontal cortex activation across valences. While this was not a clinical trial, both active treatments demonstrated an early treatment response with reduced observer-rated depression severity relative to placebo; PF-04995274 also reduced self-reported depression, state anxiety, and negative affect.

Conclusions: PF-04995274 did not show the typical antidepressant profile of negative bias reductions observed with citalopram. Instead, it was associated with distinct increased medial-frontal activation during an emotional faces task, coupled with preliminary evidence of early clinical improvement, suggesting a potential alternative pathway for antidepressant effects. Findings support further clinical trials of 5-HT4R agonists and investigation of pro-cognitive and mood effects.

Clinicaltrials.gov registration number: NCT03516604.

Data set information: Analysis scripts and anonymised behavioural data are available on OSF.

Reproduced under the paper's license (CC BY), from the paper cited above.

Repository

Its files are read in the Code ↔ Paper reader above, with 5 matches between paragraphs and lines of code.

OSF v7kgs

License: none: the authors keep all their rights
State: the link answers, verified on 27 September 2026
Evidence: files inventoried
Languages: R (16)
Size: 16 files, 16 scripts
Software Heritage: not checked
Found in: the text, “Behavioural and clinical data”
Holds: 1 notebook
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Tools: tidyverse (7 files), easystats (3 files), ggplot2 (3 files), car (2 files), ggpubr (2 files), rstatix (2 files), afex (1 file), data.table (1 file), emmeans (1 file), lme4 (1 file), patchwork (1 file)
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
  • 27 September 2026: the link answers (HTTP 200)
16 files, to read at the source

This repository has no license: its authors keep all rights. Read it at the source.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 16 scripts, each with its path and the digest of its content;
  • 5 matches between paragraphs of the paper and lines of the code (method lexical-v1);
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

Datasets cited

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: — → Cambridge University Press

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, pages, dates, 11 authors, 5 keywords, 2 funders, 45 references.

Cite

This paper

Gillespie, A., de Cates, A., Scaife, J., Blandhol, M., Martens, M., Gibson, D., Godlewska, B., Howard, W., Cowen, P., Murphy, S., & Harmer, C. (2026). Early effects of a novel 5-HT<sub>4</sub>R agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: RESTAND study. The British journal of psychiatry : the journal of mental science, 1-10. https://doi.org/10.1192/bjp.2026.10664

BibTeX

@article{gillespie2026early,
author = {Gillespie, A.L. and de Cates, A.N. and Scaife, J. and Blandhol, M. and Martens, M.A.G. and Gibson, D and Godlewska, B.R and Howard, W and Cowen, P.J. and Murphy, S.E. and Harmer, C.J.},
title = {{Early effects of a novel 5-HT\<sub\>4\</sub\>R agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: RESTAND study}},
journal = {The British journal of psychiatry : the journal of mental science},
year = {2026},
month = may,
pages = {1--10},
publisher = {Cambridge University Press},
issn = {0007-1250},
doi = {10.1192/bjp.2026.10664},
url = {https://doi.org/10.1192/bjp.2026.10664},
pmid = {42204761},
pmcid = {PMC7619257}
}

RIS

TY - JOUR
AU - Gillespie, A.L.
AU - de Cates, A.N.
AU - Scaife, J.
AU - Blandhol, M.
AU - Martens, M.A.G.
AU - Gibson, D
AU - Godlewska, B.R
AU - Howard, W
AU - Cowen, P.J.
AU - Murphy, S.E.
AU - Harmer, C.J.
TI - Early effects of a novel 5-HT<sub>4</sub>R agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: RESTAND study
T2 - The British journal of psychiatry : the journal of mental science
J2 - Br J Psychiatry
PY - 2026
DA - 2026/05/28
SP - 1
EP - 10
SN - 0007-1250
PB - Cambridge University Press
DO - 10.1192/bjp.2026.10664
UR - https://doi.org/10.1192/bjp.2026.10664
LA - en
ER -

CSL-JSON

{
"id": "10.1192/bjp.2026.10664",
"type": "article-journal",
"title": "Early effects of a novel 5-HT<sub>4</sub>R agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: RESTAND study",
"container-title": "The British journal of psychiatry : the journal of mental science",
"author": [
{
"family": "Gillespie",
"given": "A.L."
},
{
"family": "de Cates",
"given": "A.N."
},
{
"family": "Scaife",
"given": "J."
},
{
"family": "Blandhol",
"given": "M."
},
{
"family": "Martens",
"given": "M.A.G."
},
{
"family": "Gibson",
"given": "D"
},
{
"family": "Godlewska",
"given": "B.R"
},
{
"family": "Howard",
"given": "W"
},
{
"family": "Cowen",
"given": "P.J."
},
{
"family": "Murphy",
"given": "S.E."
},
{
"family": "Harmer",
"given": "C.J."
}
],
"container-title-short": "Br J Psychiatry",
"page": "1-10",
"DOI": "10.1192/bjp.2026.10664",
"PMID": "42204761",
"PMCID": "PMC7619257",
"ISSN": "0007-1250",
"publisher": "Cambridge University Press",
"URL": "https://doi.org/10.1192/bjp.2026.10664",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
28
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41398-026-04141-z [code]
Effects on hippocampal activity following novel 5-HT4 receptor agonism in unmedicated patients with depression: the RESTAND study.
Journal: Translational psychiatry
In common: afex, rstatix, easystats, 8 other tools, Zenodo 6107724, depression, 9 references, 4 authors
[2] doi:10.1038/s41467-026-73865-9 [code]
Histamine shapes the neurocomputational dynamics of human learning.
Journal: Nature communications
In common: rstatix, easystats, car, 6 other tools, cognitive, 2 references, author Philip J Cowen
[3] doi:10.1126/sciadv.aec9291 [code]
Computational mechanisms of perception in autism revealed using games inspired by rodent operant tasks.
Journal: Science advances
In common: afex, rstatix, easystats, 8 other tools, cognitive
[4] doi:10.1073/pnas.2603114123 [code]
The human hippocampus can pattern separate memories by meaning.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: afex, rstatix, easystats, 6 other tools, cognitive
[5] doi:10.1016/j.neuroimage.2026.122115 [code]
Midfrontal theta power relates to response speeding following frustrative nonreward.
Journal: NeuroImage
In common: rstatix, easystats, car, 6 other tools, cognitive
[6] doi:10.1126/sciadv.aeb8106 [code]
A thyroid hormone-mediated opsin switch initiates metamorphosis in a proto-vertebrate.
Journal: Science advances
In common: rstatix, easystats, car, 6 other tools
[7] doi:10.1038/s41467-026-74753-y [code]
A human-specific microRNA controls the timing of excitatory synaptogenesis.
Journal: Nature communications
In common: rstatix, easystats, emmeans, 6 other tools
[8] doi:10.1038/s41398-026-04010-9 [code]
Bullying victimization and brain development: a longitudinal structural magnetic resonance imaging study from adolescence to early adulthood.
Journal: Translational psychiatry
In common: rstatix, easystats, emmeans, 6 other tools
[9] doi:10.1093/bioinformatics/btag592 [code]
Network-based stratification of allele-specific expression reveals patient subgroups in Huntington's disease.
Journal: Bioinformatics (Oxford, England)
In common: rstatix, car, emmeans, 6 other tools
[10] doi:10.1073/pnas.2606871123 [code]
Oxytocin modulates the neurocomputational mechanisms engaged in learning rank relationships in social networks.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: easystats, car, emmeans, 6 other tools

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.